Blood clotting Biomarker
Collection Type: Blood, Urine
Related System: Blood clotting
Platelet Distribution Width (PDW) is a measure of the variation in platelet size (anisocytosis) reported as part of a complete blood count or platelet profile. It quantifies how uniform or heterogeneous platelets are; larger variation often indicates increased platelet production or activation. PDW is used alongside platelet count and mean platelet volume (MPV) to evaluate bleeding or clotting disorders, bone marrow activity, inflammatory states, and risk of thrombotic disease. Testing is indicated for unexplained bruising, bleeding, petechiae, thrombosis, or monitoring known hematologic or inflammatory conditions. PDW can vary with age, pregnancy, acute illness, and certain medications; small gender differences exist but are usually clinically minor.
Run our symptom checker to see if this test is right for you
Symptom Checker9-17%
Q: What happens if PDW is high?
A: High PDW means increased variation in platelet size (anisocytosis), often reflecting platelet activation or production of unusually large young platelets. It can accompany inflammation, infections, immune thrombocytopenia or bone marrow disorders such as myeloproliferative disease, and is linked to altered clotting risk. It is not diagnostic alone—doctors interpret it with platelet count, MPV and clinical context and may order further tests.
Q: What does a PDW mean?
A: PDW stands for platelet distribution width, a measure of variation in platelet size on a complete blood count. It reflects platelet heterogeneity and activation; increased PDW indicates greater size variability (seen with inflammation, thrombocytopenia, myeloproliferative disorders or active platelet destruction), while normal/low PDW suggests uniform platelets. It’s interpreted with platelet count and mean platelet volume; abnormalities need further evaluation.
Q: What deficiency causes high PDW?
A: High platelet distribution width (PDW) is commonly seen with vitamin B12 (cobalamin) deficiency and, less commonly, folate deficiency; megaloblastic ineffective hematopoiesis produces larger, immature platelets that increase size variability. Treating the deficiency often normalizes platelet indices. Other causes—acute inflammation, infection, immune or myeloproliferative disorders—should also be considered and correlated with clinical findings and blood counts.
Q: What diseases are PDW high in?
A: Elevated PDW is seen in conditions with platelet activation or heterogenous platelet size, including immune thrombocytopenia and other thrombocytopenias, myeloproliferative neoplasms (e.g., essential thrombocythemia), acute coronary syndromes and stroke, sepsis and systemic inflammatory states, diabetes, preeclampsia, disseminated intravascular coagulation, and various malignancies. It’s an adjunct marker of platelet activation and disease severity.
Q: Which cancers cause high PDW?
A: Elevated PDW has been reported in several malignancies, commonly including lung, colorectal, gastric, breast, ovarian and pancreatic cancers, as well as hepatocellular and renal cell carcinomas. Increased PDW likely reflects tumour-driven inflammation and altered platelet production/activation; it may correlate with advanced stage or poorer prognosis in some studies, but findings vary and PDW is not diagnostic alone.
Q: How to reduce high PDW in blood?
A: High PDW reflects platelet activation or underlying conditions. Reduce it by treating the root cause: manage infections, inflammation, and chronic diseases (diabetes, hypertension, dyslipidaemia); stop smoking and limit alcohol; eat a balanced diet, maintain healthy weight, stay active and hydrated. Review medications with your doctor (some drugs affect platelets) and follow prescribed treatments. Repeat testing and specialist evaluation if PDW stays high.